DIA 48th Annual Meeting
Click here to go to the previous page
Comparison of National-level Drug Utilization Patterns from Large Commercial Health Care Databases with Mini-Sentinel
Track
:
Track 14: Clinical Safety and Pharmacovigilance
Program Code:
232
Date:
Tuesday, June 26, 2012
Time:
10:00 AM to 11:30 AM
EST
CHAIR
:
Laura Governale, FDA, United States
PRESENTER
(S):
George Neyaraoally, FDA
Laura Governale, FDA, United States
Description
This session will present and discuss information generated by the Mini-Sentinel Summary Tables and Modular Programs compared with similar analyses using nationally representative commercial drug utilization databases for selected drug products.
Learning Objectives:
Describe Mini-Sentinel and the distributed data network
Compare findings from Mini-Sentinel with commercial drug utilization databases
Identify challenges of interpreting drug utilization data across different databases.
Learning Objectives:
Describe Mini-Sentinel and the distributed data network
Compare findings from Mini-Sentinel with commercial drug utilization databases
Identify challenges of interpreting drug utilization data across different databases.
This session is a part of:
Handout Online
